Pharmacological properties of thiazolinobutazone (LAS 11871). II. Analgesic and antipyretic effects.
D000085:Acetates; D000284:Administration, Oral; D000818:Animals; D001920:Bradykinin; D004353:Drug Evaluation, Preclinical; D007249:Inflammation / Q000139:chemically induced / Q000188:drug therapy; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D008297:Male; D051379:Mice; D010146:Pain / Q000139:chemically induced / Q000188:drug therapy; D010653:Phenylbutazone / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D011312:Pressure; D051381:Rats; D011930:Reaction Time / Q000187:drug effects; D013623:Tail; D013844:Thiazoles / Q000494:pharmacology / Q000627:therapeutic use*
D000085:Acetates; D013844:Thiazoles; D010653:Phenylbutazone; D001920:Bradykinin